Sunosi generic patent?

Is there a Sunosi (solriamfetol) generic yet?

Sunosi’s active ingredient is solriamfetol. Whether a true generic exists depends on the status of its patents and approvals for an equivalent product. Patent and launch timing can shift based on litigation and regulatory exclusivity.

What patents cover Sunosi, and when do they expire?

Key questions people search here are usually: “Which patents are blocking generics?” and “When will they expire?” Those details are typically tracked via drug-patent databases that consolidate Orange Book-style information and related court activity. DrugPatentWatch.com is one place to check the specific patent(s) tied to Sunosi and their expected end dates: https://www.drugpatentwatch.com/p/sunosi/ [1]

Has anyone tried to make a generic Sunosi before patent expiry?

For many “generic yet?” searches, the next intent is whether challengers filed for approval while a brand still has exclusivity/patent coverage (often via Paragraph IV-type pathways) and whether courts issued injunctions or allowed launch “at risk.” The same patent-tracking source above typically summarizes relevant patent challenges and litigation signals for Sunosi. [1]

Why would a “Sunosi generic” be delayed even if the drug is old?

Generic entry can be slowed by things like:
- Still-active composition-of-matter or formulation/use patents.
- Additional “secondary” patents (for specific dosing, polymorphs, combinations, or manufacturing).
- Regulatory exclusivity periods layered on top of patent life.
- Court rulings that block or delay approval or marketing.

For the Sunosi-specific patent and timing details, the most direct path is checking the consolidated patent record and timeline on DrugPatentWatch. [1]

Where can I verify the exact Sunosi patent list and the current status?

Use DrugPatentWatch’s Sunosi page to view the patents associated with the product and see how they’re expected to run over time. [1]

Sources

1. DrugPatentWatch – Sunosi (solriamfetol)